Skip to content
2000
Volume 21, Issue 5
  • ISSN: 1567-2026
  • E-ISSN: 1875-5739

Abstract

Background

Plasma osteoprotegerin (OPG) has been linked to poor prognosis following stroke, but its impact on post-stroke cognitive impairment (PSCI) is unknown. The purpose of our work was to analyze the relationship of OPG with PSCI.

Methods

Our study included 613 ischemic stroke subjects with plasma OPG levels. We used the Mini-mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) to assess PSCI. PSCI was defined as MMSE score <25 or MoCA score <23.

Results

As assessed by the MMSE score, the adjusted odds ratio for PSCI in the highest OPG tertile was 1.77, with a 95% confidence interval of 1.09 to 2.89 (=0.021), compared to that in the lowest tertile. We observed a positive linear relationship of plasma OPG levels with 3-month PSCI ( for linearity=0.046). Incorporating plasma OPG into conventional risk factors enhanced PSCI risk reclassification (all <0.05). Consistent results were discovered when PSCI was evaluated using the MoCA score.

Conclusion

High plasma OPG levels were related to an elevated risk of 3-month PSCI, indicating that OPG might be an effective biomarker for predicting PSCI.

Loading

Article metrics loading...

/content/journals/cnr/10.2174/0115672026368528250113080256
2025-01-29
2025-08-27
Loading full text...

Full text loading...

References

  1. KimK.Y. ShinK.Y. ChangK.A. Potential biomarkers for post-stroke cognitive impairment: A systematic review and meta-analysis.Int. J. Mol. Sci.202223260210.3390/ijms2302060235054785
    [Google Scholar]
  2. PascoeM. SkiC.F. ThompsonD.R. LindenT. Serum cholesterol, body mass index and smoking status do not predict long-term cognitive impairment in elderly stroke patients.J. Neurol. Sci.201940611647610.1016/j.jns.2019.11647631627085
    [Google Scholar]
  3. QuY. ZhuoL. LiN. HuY. ChenW. ZhouY. WangJ. TaoQ. HuJ. NieX. ZhanS. Prevalence of post-stroke cognitive impairment in China: A community-based, cross-sectional study.PLoS One2015104e012286410.1371/journal.pone.012286425874998
    [Google Scholar]
  4. KwonH.S. LeeD. LeeM.H. YuS. LimJ.S. YuK.H. OhM.S. LeeJ.S. HongK.S. LeeE.J. KangD.W. KwonS.U. PICASSO investigators Post-stroke cognitive impairment as an independent predictor of ischemic stroke recurrence: PICASSO sub-study.J. Neurol.2020267368869310.1007/s00415‑019‑09630‑431720819
    [Google Scholar]
  5. OksalaN.K.J. JokinenH. MelkasS. OksalaA. PohjasvaaraT. HietanenM. VatajaR. KasteM. KarhunenP.J. ErkinjunttiT. Cognitive impairment predicts poststroke death in long-term follow-up.J. Neurol. Neurosurg. Psychiatry200980111230123510.1136/jnnp.2009.17457319620138
    [Google Scholar]
  6. CummingT.B. MarshallR.S. LazarR.M. Stroke, cognitive deficits, and rehabilitation: Still an incomplete picture.Int. J. Stroke201381384510.1111/j.1747‑4949.2012.00972.x23280268
    [Google Scholar]
  7. AbedinM. OmlandT. UelandT. KheraA. AukrustP. MurphyS.A. JainT. GruntmanisU. McGuireD.K. de LemosJ.A. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).Am. J. Cardiol.200799451351810.1016/j.amjcard.2006.08.06417293196
    [Google Scholar]
  8. RochetteL. MelouxA. RigalE. ZellerM. CottinY. VergelyC. The role of osteoprotegerin and its ligands in vascular function.Int. J. Mol. Sci.201920370510.3390/ijms2003070530736365
    [Google Scholar]
  9. VikA. MathiesenE.B. BroxJ. WilsgaardT. NjølstadI. JørgensenL. HansenJ.B. Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: The Tromsø Study.J. Thromb. Haemost.20119463864410.1111/j.1538‑7836.2011.04222.x21284802
    [Google Scholar]
  10. CaoY. CuiC. ZhaoH. PanX. LiW. WangK. MaA. Plasma osteoprotegerin correlates with stroke severity and the occurrence of microembolic signals in patients with acute ischemic stroke.Dis. Markers201920191710.1155/2019/309036431191747
    [Google Scholar]
  11. ZhuZ. GuoD. ZhangK. YangP. JiaY. ShiM. PengY. ChenJ. WangA. XuT. ZhangY. HeJ. Osteoprotegerin and ischemic stroke prognosis: A prospective multicenter study and mendelian randomization analysis.Stroke202354250951710.1161/STROKEAHA.122.04080036511149
    [Google Scholar]
  12. EmanueleE. PerosE. ScioliG. D’AngeloA. OlivieriC. MontagnaL. GeroldiD. Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer’s disease.Int. J. Mol. Med.200413684985310.3892/ijmm.13.6.84915138623
    [Google Scholar]
  13. DugganM.R. ButlerL. PengZ. DayaG.N. MoghekarA. AnY. RappS.R. HaydenK.M. ShadyabA.H. NataleG. LiuL. SnetselaarL. MoaddelR. RebholzC.M. SullivanK. BallantyneC.M. ResnickS.M. FerrucciL. WalkerK.A. Plasma proteins related to inflammatory diet predict future cognitive impairment.Mol. Psychiatry20232841599160910.1038/s41380‑023‑01975‑736737481
    [Google Scholar]
  14. HopeS. MelleI. AukrustP. AgartzI. LorentzenS. SteenN.E. DjurovicS. UelandT. AndreassenO.A. Osteoprotegerin levels in patients with severe mental disorders.J. Psychiatry Neurosci.201035530431010.1503/jpn.09008820569643
    [Google Scholar]
  15. HeJ. ZhangY. XuT. ZhaoQ. WangD. ChenC.S. TongW. LiuC. XuT. JuZ. PengY. PengH. LiQ. GengD. ZhangJ. LiD. ZhangF. GuoL. SunY. WangX. CuiY. LiY. MaD. YangG. GaoY. YuanX. BazzanoL.A. ChenJ. CATIS Investigators Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: The CATIS randomized clinical trial.JAMA2014311547948910.1001/jama.2013.28254324240777
    [Google Scholar]
  16. BuX. ZhangY. BazzanoL.A. XuT. GuoL. WangX. ZhangJ. CuiY. LiD. ZhangF. JuZ. XuT. ChenC.S. ChenJ. HeJ. Effects of early blood pressure reduction on cognitive function in patients with acute ischemic stroke.Int. J. Stroke20161191009101910.1177/174749301666009427412188
    [Google Scholar]
  17. BrottT. AdamsH.P.Jr OlingerC.P. MarlerJ.R. BarsanW.G. BillerJ. SpilkerJ. HolleranR. EberleR. HertzbergV. Measurements of acute cerebral infarction: A clinical examination scale.Stroke198920786487010.1161/01.STR.20.7.8642749846
    [Google Scholar]
  18. AdamsH.P.Jr BendixenB.H. KappelleL.J. BillerJ. LoveB.B. GordonD.L. MarshE.E.III Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke1993241354110.1161/01.STR.24.1.357678184
    [Google Scholar]
  19. FolsteinM.F. FolsteinS.E. McHughP.R. “Mini-mental state”.J. Psychiatr. Res.197512318919810.1016/0022‑3956(75)90026‑61202204
    [Google Scholar]
  20. NasreddineZ.S. PhillipsN.A. BédirianV. CharbonneauS. WhiteheadV. CollinI. CummingsJ.L. ChertkowH. The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment.J. Am. Geriatr. Soc.200553469569910.1111/j.1532‑5415.2005.53221.x15817019
    [Google Scholar]
  21. OwenR.K. CooperN.J. QuinnT.J. LeesR. SuttonA.J. Network meta-analysis of diagnostic test accuracy studies identifies and ranks the optimal diagnostic tests and thresholds for health care policy and decision-making.J. Clin. Epidemiol.201899647410.1016/j.jclinepi.2018.03.00529548843
    [Google Scholar]
  22. CarsonN. LeachL. MurphyK.J. A re‐examination of montreal cognitive assessment (MoCA) cutoff scores.Int. J. Geriatr. Psychiatry201833237938810.1002/gps.475628731508
    [Google Scholar]
  23. DurrlemanS. SimonR. Flexible regression models with cubic splines.Stat. Med.19898555156110.1002/sim.47800805042657958
    [Google Scholar]
  24. PencinaM.J. D’ AgostinoR.B.Sr D’ AgostinoR.B.Jr VasanR.S. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond.Stat. Med.200827215717210.1002/sim.292917569110
    [Google Scholar]
  25. Collin-OsdobyP. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.Circ. Res.200495111046105710.1161/01.RES.0000149165.99974.1215564564
    [Google Scholar]
  26. SongT.J. KimJ. YangS.H. ParkJ.H. LeeH.S. NamC.M. LeeO.H. KimY.D. NamH.S. HeoJ.H. Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients.Biomarkers201217873874410.3109/1354750X.2012.72702723030274
    [Google Scholar]
  27. JensenJ.K. UelandT. AtarD. GullestadL. MickleyH. AukrustP. JanuzziJ.L. Osteoprotegerin concentrations and prognosis in acute ischaemic stroke.J. Intern. Med.2010267441041710.1111/j.1365‑2796.2009.02163.x19895657
    [Google Scholar]
  28. HopeS. HosethE. DiesetI. MørchR.H. AasM. AukrustP. DjurovicS. MelleI. UelandT. AgartzI. UelandT. WestlyeL.T. AndreassenO.A. Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls.Schizophr. Res.20151652-318819410.1016/j.schres.2015.04.00425956633
    [Google Scholar]
  29. ShimamuraM. NakagamiH. OsakoM.K. KurinamiH. KoriyamaH. ZhengdaP. TomiokaH. TenmaA. WakayamaK. MorishitaR. OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice.Proc. Natl. Acad. Sci. USA2014111228191819610.1073/pnas.140054411124847069
    [Google Scholar]
  30. HosethE.Z. WestlyeL.T. HopeS. DiesetI. AukrustP. MelleI. HaukvikU.K. AgartzI. UelandT. UelandT. AndreassenO.A. Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls.Acta Psychiatr. Scand.20161331536210.1111/acps.1246726189721
    [Google Scholar]
  31. JeffersonA.L. MassaroJ.M. WolfP.A. SeshadriS. AuR. VasanR.S. LarsonM.G. MeigsJ.B. KeaneyJ.F.Jr LipinskaI. KathiresanS. BenjaminE.J. DeCarliC. Inflammatory biomarkers are associated with total brain volume.Neurology200768131032103810.1212/01.wnl.0000257815.20548.df17389308
    [Google Scholar]
  32. SchirmerM.D. DonahueK.L. NardinM.J. DalcaA.V. GieseA.K. EthertonM.R. MockingS.J.T. McIntoshE.C. ColeJ.W. HolmegaardL. JoodK. Jimenez-CondeJ. KittnerS.J. LemmensR. MeschiaJ.F. RosandJ. RoquerJ. RundekT. SaccoR.L. SchmidtR. SharmaP. SlowikA. StanneT.M. VagalA. WasseliusJ. WooD. BevanS. HeitschL. PhuahC.L. StrbianD. TatlisumakT. LeviC.R. AttiaJ. McArdleP.F. WorrallB.B. WuO. JernC. LindgrenA. MaguireJ. ThijsV. RostN.S. MRI-GENIE and GISCOME Investigators and the International Stroke Genetics Consortium Brain volume: An important determinant of functional outcome after acute ischemic stroke.Mayo Clin. Proc.202095595596510.1016/j.mayocp.2020.01.02732370856
    [Google Scholar]
  33. MałeckiM. OkulewiczP. LisakM. SafranowK. DomańskiL. CiechanowskiK. GołembiewskaE. Osteoprotegerin and inflammation in incident peritoneal dialysis patients.J. Clin. Med.2024138234510.3390/jcm1308234538673616
    [Google Scholar]
  34. ChengY. ZhuH. LiuC. LiL. LinF. GuoY. GuC. SunD. GaoY. HeG. SunS. XueS. Systemic immune-inflammation index upon admission correlates to post-stroke cognitive impairment in patients with acute ischemic stroke.Aging (Albany NY)202416108810882110.18632/aging.20583938771141
    [Google Scholar]
  35. KimJ.Y. ParkY.J. KimK.J. ChoiJ.J. KimW.U. ChoC.S. Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress.Arthritis Rheum.20136582172218210.1002/art.3799723666878
    [Google Scholar]
  36. LucaM. LucaA. Oxidative stress-related endothelial damage in vascular depression and vascular cognitive impairment: Beneficial effects of aerobic physical exercise.Oxid. Med. Cell. Longev.201920191610.1155/2019/806704531929857
    [Google Scholar]
/content/journals/cnr/10.2174/0115672026368528250113080256
Loading
/content/journals/cnr/10.2174/0115672026368528250113080256
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test